Pepsi Bottling Ventures announced that its network was breached by info-stealing malware, exposing sensitive personal and financial information.
The breach happened on or around December 23, 2022, which Pepsi Bottling Ventures only discovered on January 10,
According to Derek Hill, CEO of Pepsi Bottling Ventures America's largest manufacturer and distributor of Pepsi-Cola beverages, they took prompt action to contain the incident and secure their systems.
According to the preliminary investigation, the intruder accessed internal IT systems and installed malware before downloading information that included names, home addresses, email addresses, and government-issued identification.
Additionally, passwords, PIN codes, and other access numbers, along with digital signatures, benefit and employment information, and health insurance claims and policy numbers were also stolen.


Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination
Asian Currencies Steady as U.S.-Iran Ceasefire Extension Hopes Weigh on Dollar
Macquarie Names Five Taiwan AI Stocks Set to Benefit From Data Center Growth in 2026
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand
Autodesk Beats Q1 Estimates, Acquires MaintainX for $3.6 Billion
Brazil Extends Fuel Subsidies and Tax Relief Measures Through July 2026 Amid Global Oil Market Volatility
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
US Quantum Stocks Surge After $2 Billion Government Investment
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook
New World Screwworm Found Near U.S. Border Raises Threat to Cattle Industry and Beef Prices
Sable Offshore Wins Key Court Battle Over California Oil Pipeline
ECB’s Philip Lane Warns Middle East Conflict Could Keep Inflation Elevated
Kevin Warsh Faces Early Fed Test as Inflation Risks Challenge Rate-Cut Expectations
Dow Hits Record High as Healthcare and Consumer Stocks Lead Wall Street Rally
Trump Adviser’s Investment in Thrive Capital Draws Scrutiny Over Federal Contracts
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge 



